肺癌手术后性别与生存:瑞典全国队列研究
基于瑞典全国质量登记,纳入6356例肺癌肺切除患者,采用逆概率加权和Cox回归分析。女性全因死亡风险低于男性(HR 0.73,95%CI 0.67-0.79),1、5、10年绝对生存差异分别为3.0%、10%、12%,10年限制性平均生存时间差0.84年。
要点
- 肺癌肺切除术后女性预后显著优于男性,校正多因素后HR 0.73。
- 绝对生存优势随时间增加:1年3.0%,5年10%,10年12%。
- 生存优势在年龄、合并症、社会经济、手术类型、肿瘤特征等亚组一致。
核心结论
- 女性肺癌肺切除术后全因死亡风险显著低于男性,且绝对生存差异随时间扩大。
研究设计与样本
- 全国性人群基础观察性队列研究,纳入瑞典国家胸科手术质量登记6356例肺癌肺切除患者,个体级链接其他全国健康数据登记。
- 采用逆概率治疗加权校正基线差异,Cox回归评估女性与全因死亡关联,柔性参数生存模型估计绝对生存差异及95%CI,并计算限制性平均生存时间差。
主要发现
- 女性较男性全因死亡风险降低(HR 0.73,95%CI 0.67-0.79)。
- 1、5、10年绝对生存差异分别为3.0%(95%CI 2.2%-3.8%)、10%(95%CI 7.0%-12%)、12%(95%CI 8.5%-15%)。
- 10年限制性平均生存时间差为0.84年(95%CI 0.61-1.07年)。
- 亚组分析结果一致。
临床怎么用
- 肺癌肺切除术后预后评估应考虑性别因素,女性生存预期更优。
- 术后随访和风险分层可参考性别相关的生存差异进行个体化调整。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Prior reports on a possible female survival advantage in both surgical and nonsurgical cohorts of patients with lung cancer are conflicting. Previously reported differences in survival after lung cancer surgery could be the result of insufficient control for disparities in risk factor profiles in men and women. RESEARCH QUESTION: Do women who undergo pulmonary resections for lung cancer have a better prognosis than men when taking a wide range of prognostic factors into account? STUDY DESIGN AND METHODS: We performed a nationwide population-based observational cohort study analyzing sex-specific survival after pulmonary resections for lung cancer. We identified 6356 patients from the Swedish National Quality Register for General Thoracic Surgery and performed individual-level record linkage to other national health-data registers to acquire detailed information regarding comorbidity, socioeconomic status, and vital status. Inverse probability of treatment weighting was used to account for differences in baseline characteristics. The association between female sex and all-cause mortality was assessed with Cox regression models, and flexible parametric survival models were used to estimate the absolute survival differences with 95% CIs. We also estimated the difference in restricted mean survival time. RESULTS: We observed a lower risk of death in women compared with men (hazard ratio, 0.73; 95% CI, 0.67-0.79). The absolute survival difference at 1, 5, and 10 years was 3.0% (95% CI, 2.2%-3.8%), 10% (95% CI, 7.0%-12%), and 12% (95% CI, 8.5%-15%), respectively. The restricted mean survival time difference at 10 years was 0.84 year (95% CI, 0.61-1.07 years). The findings were consistent across several subgroups. INTERPRETATION: Women who underwent pulmonary resections for lung cancer had a significantly better prognosis than men. The survival advantage was evident regardless of age, common comorbidities, socioeconomic status, lifestyle factors, physical performance, type and extent of surgery, tumor characteristics, and stage of disease. TRIAL REGISTRY: ClinicalTrials.gov; No.: NCT03567538; URL: www.clinicaltrials.gov.
引用
- Sachs E, Sartipy U, Jackson V, et al. Sex and Survival After Surgery for Lung Cancer: A Swedish Nationwide Cohort. Chest. 2020. PMID: 33217414. doi:10.1016/j.chest.2020.11.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。